Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Flushing in RRMS Patients Treated with Tecfidera
NCT02090413Phase 4Completed
- Sponsor
- Biogen
- Start
- May 2014
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of aspirin, sponsored by Biogen. Started May 2014; status: completed.
02
Drugs
aspirin
Beyond the preview
Go deeper on NCT02090413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02090413.